Bacterial peptidoglycan polysaccharides in sterile human spleen induce proinflammatory cytokine production by human blood cells

Journal of Infectious Diseases

Volumn 179, Issue 6, 1999, Pages 1459-1468

  Schrijver, Ingrid A ^a,b   Melief, Marie José ^a   Eulderink, Frits ^a   Hazenberg, Maarten P ^a   Laman, Jon D ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 6; PEPTIDOGLYCAN; POLYMYXIN B; POLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN ISOLATION; SPLEEN CELL;

ANTIGEN-PRESENTING CELLS; BLOOD CELLS; CYTOKINES; GRAM-POSITIVE BACTERIA; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-6; MURAMIC ACIDS; PEPTIDOGLYCAN; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032992812     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314761     Document Type: Article

References (40)

1. 1. Schleifer KH, Kandler O. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev 1972;36:407-77.
2. 2. Kengatharan KM, De Kimpe S, Robson C, Foster SJ, Thiemermann C. Mechanism of gram-positive shock: identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure. J Exp Med 1998;188:305-15.
3. 3. Rietschel ET, Brade H. Bacterial endotoxins. Sci Am 1992;267:54-61.
4. 4. Glauser MP, Zanetti G, Baumgartner JD, Cohen J. Septic shock: pathogenesis. Lancet 1991;338:732-6.
5. 5. Greenblatt J, Boackle RJ, Schwab JH. Activation of the alternate complement pathway by peptidoglycan from streptococcal cell wall. Infect Immun 1978;19:296-303.
6. 6. Mattsson E, Rollof J, Verhoef J, Van Dijk H, Fleer A. Serum-induced potentiation of tumor necrosis factor alpha production by human monocytes in response to staphylococcal peptidoglycan: involvement of different serum factors. Infect Immun 1994;62:3837-43.
7. 7. Guthrie LA, McPhail LC, Henson PM, Johnston RB Jr. Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide: evidence for increased activity of the superoxide-producing enzyme. J Exp Med 1984;160:1656-71.
8. 8. Martinez-Martinez L, Timmerman CP, Fleer A, Verhoef J. Chemiluminescence of human polymorphonuclear leucocytes after stimulation with whole cells and cell-wall components of Staphylococcus epidermidis. J Med Microbiol 1993;39:196-203.
9. 9. Timmerman CP, Mattsson E, Martinez-Martinez L, et al. Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans. Infect Immun 1993;61:4167-72.
10. 10. Heumann D, Barras C, Severin A, Glauser MP, Tomasz A. Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytcs. Infect Immun 1994;62:2715-21.
11. 11. Weidemann B, Brade H, Rietschel ET, et al. Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infect Immun 1994;62:4709-15.
12. 12. Weidemann B, Schletter J, Dziarski R, et al. Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes. Infect Immun 1997;65:858-64.
13. 13. Park H, Schumacher HR, Zeiger AR, Rosenbaum JT. Antibodies to peptidoglycan in patients with spondylarthritis: a clue to disease aetiology? Ann Rheum Dis 1984;43:725-28.
14. 14. Sartor RB. Importance of intestinal mucosal immunity and luminal bacterial cell wall polymers in the aetiology of inflammatory joint diseases. Baillieres Clin Rheumatol 1989;3:223-45.
15. 15. Schwab JH. Phlogistic properties of peptidoglycan-polysaccharide polymers from cell walls of pathogenic and normal-flora bacteria which colonize humans. Infect Immun 1993;61:4535-9.
16. 16. Hazenberg MP, Klasen IS, Kool J, Ruseler-van Embden JG, Severijnen AJ. Are intestinal bacteria involved in the etiology of rheumatoid arthritis? Apmis 1992;100:1-9.
17. 17. Hazenberg MP. Intestinal flora bacteria and arthritis: why the joint? Scand J Rheumatol Suppl 1995;101:207-11.
18. 125I-labeled peptidoglycan-polysaccharide fragments from group A and group D streptococci. Infect Immun 1986;52:390-6.
19. 19. Gilbart J, Fox A. Elimination of group A streptococcal cell walls from mammalian tissues. Infect Immun 1987;55:1526-8.
20. 20. Park H, Schumacher HR, Zeiger AR, Rosenbaum JT. Antibodies to peptidoglycan in patients with spondylarthritis: a clue to disease aetiology? Ann Rheum Dis 1984;43:725-8.
21. 21. Lehtonen L, Kortekangas P, Oksman P, Eerola E, Aro H, Toivanen A. Synovial fluid muramic acid in acute inflammatory arthritis. Br J Rheumatol 1994;33:1127-30.
22. 22. Lehtonen L, Eerola E, Oksman P, Toivanen P. Muramic acid in peripheral blood leukocytes of healthy human subjects. J Infect Dis 1995;171:1060-4.
23. 23. Melief MJ, Hoijer MA, Van Paassen HC, Hazenberg MP. Presence of bacterial flora-derived antigen in synovial tissue macrophages and dendritic cells. Br J Rheumatol 1995;34:1112-6.
24. 24. Kool J, De Visser H, Gerrits-Boeye MY, et al. Detection of intestinal flora-derived bacterial antigen complexes in splenic macrophages of rats. J Histochem Cytochem 1994;42:1435-41.
25. 25. Hoijer MA, Melief MJ, van Helden-Mceuwsen CG, Eulderink F, Hazenberg MP. Detection of muramic acid in a carbohydrate fraction of human spleen. Infect Immun 1995;63:1652-7.
26. 26. Lichtman SN, Keku J, Schwab JH, Sartor RB. Evidence for peptidoglycan absorption in rats with experimental small bowel bacterial overgrowth. Infect Immun 1991;59:555-62.
27. 27. Hazenberg MP, Pennock-Schroder AM, Wensinck F, Van de Merwe JP. Effect of a soluble bacterial carbohydrate fraction on the viscosity of intestinal contents in healthy subjects and patients with Crohn's disease. Eur J Clin Invest 1989;19:61-4.
28. 28. Hadzija O. A simple method for the quantitative determination of muramic acid. Anal Biochem 1974;60:512-7.
29. 29. Hazenberg MP, de Visser H. Assay for N-acetylmuramyl-L-alanine amidase in serum by determination of muramic acid released from the peptidoglycan of Brevibacterium divaricatum. Eur J Clin Chem Clin Biochem 1992;30:141-4.
30. 30. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
31. 31. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurements with the folin phenol reagent. J Biol Chem 1951;193:265-75.
32. 32. Miller RS, Hoskins LC. Mucin degradation in human colon ecosystems: fecal population densities of mucin-degrading bacteria estimated by a "most probable number" method. Gastroenterology 1981;81:759-65.
33. 33. Glauner B. Analyse des Mureins von Escherishia coli mit Hilfe der Hochdruckflüssigkeitschromatographic. Tübingen, Germany: Diplomarbeit, 1982.
34. 34. Espevik T, Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 1986;95:99-105.
35. 35. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
36. 36. Hopkins SJ, Humphreys M. Simple, sensitive and specific bioassay of interleukin-1. J Immunol Methods 1989;120:271-6.
37. 37. Debets R, Van Joost T, Benner R, Prens EP. Psoriatic epidermal cells release elevated levels of immunoreactive and biologically active interleukins 1 and 6: modulation of corticosteroid treatment. In: Bernard BA, Shroot B, eds. Pharmacol skin: from molecular biology to therapeutics. Basel, Switzerland: S Karger, 1993;5:158-66.
38. 38. Aarden LA, de Groot R, Schaap OL, Lansdorp PM. Production of hybridoma growth factor by human monocytes. Eur J Immunol 1987;17:1411-6.
39. 39. Kool J, Ruseler-van Embden JG, van Lieshout LM, et al. Induction of arthritis in rats by soluble peptidoglycan-polysaccharide complexes produced by human intestinal flora. Arthritis Rheum 1991;34:1611-6.
40. 40. Rook GAW, Stanford JL. Give us this day our daily germs. Immunol Today 1998;19:113-6.